Women SHINE Intervention for HIV/AIDS
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a program called Women SHINE, designed to assist women with HIV/AIDS who have experienced violence and struggle with medication adherence. The study will compare two groups: one receiving Women SHINE support and the other receiving basic self-care resources (control group). Women with HIV who have experienced violence as adults and find it difficult to consistently take their medication might be suitable candidates. The goal is to determine if Women SHINE can improve medication adherence and emotional health. As an unphased trial, this study offers participants a unique opportunity to contribute to research that could enhance support systems for women facing similar challenges.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, since participants must be currently prescribed ART (HIV medication), it seems you should continue taking it.
What prior data suggests that the Women SHINE intervention is safe?
Research shows that trauma-informed programs like Women SHINE are generally well-received. These programs provide peer support and education to assist women with HIV/AIDS who have experienced interpersonal violence.
Previous studies on similar programs have shown improvements in mental health and social support without major safety issues. Participants often report feeling better and developing stronger coping skills. Significant negative effects from these programs have not been reported.
Overall, evidence suggests that the Women SHINE program is safe, enhancing emotional and social support without introducing physical or medical risks.12345Why are researchers excited about this trial?
Researchers are excited about the Women SHINE intervention because it offers a holistic and peer-supported approach to addressing HIV/AIDS in women, setting it apart from traditional medical treatments. Unlike standard care, which often focuses solely on medication, Women SHINE includes a combination of video-based one-on-one peer navigation and weekly psycho-education support group sessions. This method emphasizes mental health, interpersonal violence, and substance use alongside HIV care, providing a comprehensive support system. The integration of peer navigators who share similar experiences with participants adds a unique layer of relatability and support, potentially leading to improved health outcomes and empowerment for women living with HIV/AIDS.
What evidence suggests that this trial's treatments could be effective for women living with HIV/AIDS?
Research has shown that the Women SHINE program, a treatment in this trial, might assist women with HIV/AIDS who have experienced violence and struggle with medication adherence. Women in similar programs have improved their adherence to antiretroviral therapy (ART), crucial for controlling the virus. The Women SHINE intervention provides personalized support from peer supporters and group therapy sessions, enhancing emotional health and coping skills. This support can significantly help women maintain medication consistency and improve overall health. Early signs suggest this approach may improve both mental health and medication habits.16789
Who Is on the Research Team?
Jamila K Stockman, PhD, MPH
Principal Investigator
University of California, San Diego
Are You a Good Fit for This Trial?
This trial is for cisgender women over 18 living with HIV/AIDS who have experienced interpersonal violence as adults and are not fully adherent to their antiretroviral therapy (ART). Participants must speak English or Spanish, have internet access, and cannot be involved in another adherence intervention.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Women SHINE intervention arm receives a four-month program including video-based peer navigation support, 7 weekly psychoeducation support group sessions, and access to a static website with resources.
Control
Control arm receives one 60-minute group session on self-care and well-being and access to a static website with resources.
Follow-up
Participants are monitored for improvements in ART adherence, PTSD symptoms, and emotion regulation at 4-, 8-, and 12-months post-randomization.
What Are the Treatments Tested in This Trial?
Interventions
- Control
- Women SHINE
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator